🇫🇷
France · FR · FR:68806037
METYRAPONE ESTEVE 250 mg, capsule molle
ReimbursedATC V04CD01
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerESTEVE PHARMACEUTICALS (ESPAGNE)
CountryFR (France)
ATC codeV04CD01
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400930007327flacon(s) polyéthylène haute densité (PEHD) de 50 capsule(s)EUR 258.31
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "68806037",
"date_amm": "2015-02-05",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code V04CD01.
Access this data programmatically
Query METYRAPONE ESTEVE 250 mg, capsule molle and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.